[Source: Daily Nation, by Bernadine Mutanu]
Kenya is among 92 low-and-middle-income countries that are set to benefit from a low-cost Covid-19 vaccine that is currently on trial from 2021.
The Melinda Gates Foundation and The Vaccine Alliance have contracted Serum Institute of India (SII) to accelerate manufacture of 100 million doses of “safe and effective Covid-19 vaccines for low- and middle-income countries in 2021.”
The vaccines will be made available to nations included in…
